Links
[1] https://www.sciensano.be/sites/default/files/prevalence_of_antisarscov-2_antibodies_and_potential_determinants_among_the_belgian_adult_population.pdf
[2] https://doi.org/10.3390/v14050920
[3] https://www.sciensano.be/nl/people/victoria-leclercq/biblio
[4] https://www.sciensano.be/nl/biblio?f%5Bauthor%5D=181343&f%5Bsearch%5D=Nayema%20Van%20den%20Houte
[5] https://www.sciensano.be/nl/people/lydia-gisle/biblio
[6] https://www.sciensano.be/nl/people/inge-roukaerts/biblio
[7] https://www.sciensano.be/nl/biblio?f%5Bauthor%5D=85377&f%5Bsearch%5D=Cyril%20Barbezange
[8] https://www.sciensano.be/nl/people/isabelle-desombere/biblio
[9] https://www.sciensano.be/nl/biblio?f%5Bauthor%5D=83736&f%5Bsearch%5D=Els%20Duysburgh
[10] https://www.sciensano.be/nl/people/johan-van-der-heyden/biblio
[11] https://www.sciensano.be/nl/biblio?f%5Bkeyword%5D=37214&f%5Bsearch%5D=SARS-CoV-2%20%3B%20COVID-19%20%3B%20antibodies%20%3B%20seroprevalence%20%3B%20cohort%20%3B%20population-based%20study%20%3B%20Belgium
[12] https://www.sciensano.be/nl/projecten/studie-over-de-prevalentie-van-antistoffen-tegen-het-coronavirus-sars-cov-2-bij-de-belgische
[13] https://www.sciensano.be/nl/gezondheidsonderwerpen/coronavirus